Non Small Cell Lung Cancer Life Expectancy

SCLC accounts for approximately 20% of all lung cancers. Non Small Cell Lung Cancer Life Expectancy It is often referred to as oat cell carcinoma because the small cells of the lung have a similar appearance to oats. SCLC develops when there is a rapid and uncontrollable growth in the small cells of the lung that eventually leads to a malignant (cancerous) tumour forming. In this article I will be discussing four risk factors that can contribute to the development of this cancer.

1) SMOKING:- Tobacco smoke is the leading risk factor for all types of lung cancer. It is strongly linked with SCLC and is believed to be responsible for over 90% of cases. Even if you do not smoke personally being around others that do can significantly increase your risk of contracting this type of cancer.

The reason that tobacco smoke is such a strong risk factor for SCLC is that it is full of carcinogens (cancer causing substances). According to Cancer Research UK tobacco smoke can contain up to 70 different carcinogens. These carcinogens have been scientifically proven to damage DNA and alter important genes which can then cause your body’s cells to multiply in a rapid and uncontrollable way. When you inhale tobacco smoke (either directly through a cigarette or indirectly through second hand smoke) these carcinogens go straight to your lungs greatly improving the risk of lung cancer and SCLC developing.

2) URANIUM:- Exposure to uranium is thought to increase your risk of developing all types of lung cancer. However, it is most strongly linked with the development of SCLC. A combination of uranium exposure and exposure to tobacco smoke increases your chances of developing SCLC even further.

Lung Cancer Secrets Revealed Click here

The reason uranium increases your risk of contracting SCLC is that uranium ores are radioactive. Radon (a gas that is created when uranium breaks down) is also highly radioactive. Research has shown that prolonged exposure to radioactive materials can cause cancer. When people are exposed to uranium it is often inhaled meaning that the radioactive materials are carried directly to the lungs. These radioactive materials can then cause cancerous growth in the small cells of the lungs.

3) ASBESTOS:- Asbestos is most strongly linked with a rare kind of cancer called mesothelioma. However, it has also been linked with increasing the risk for other types of lung cancer including SCLC. Asbestos exposure combined with tobacco smoke greatly increases your small cell lung cancer risk.

The reason asbestos increases your chances of developing SCLC is that when it becomes disturbed very fine fibres are released. These fibres irritate the body’s cells and can lead to the development of cancer. If they become lodged in the small cells of the lung they can stimulate the development of SCLC.

4) POOR DIET:- According to Cancer Research UK not getting enough fruit and vegetables in your diet can increase your risk of developing SCLC. The reason for this is that both fruits and vegetables are a rich source of vitamins, anti-oxidants and other chemicals that help prevent cell damage. If you are deficient in any of these then the small cells of your lung may be more susceptible to cancer.

SCLC is not a pleasant condition. However, unlike many other types of cancer where the risk factors are unclear, SCLC has a number of very definite risk factors. In particular smoking has been scientifically proven to significantly increase your small cell lung cancer risk. You can have a direct impact on your chances of getting this cancer. I hope this article has helped you see that.

Whilst every intention has been made to make this article accurate and informative, it is intended for general information only. Small cell lung cancer is a very serious, life threatening condition and you should discuss any concerns, treatments or lifestyle changes fully with your doctor.

lung cancer treatment breakthroughs Click here

About the Author

lung cancer best treatment Click here

GRACEcast-011_Lung-Cancer_Second Line Treatment for NSCLC

NEW TREATMENT PARADIGMS IN NON SMALL CELL LUNG CANCER oncology oncologist $0.00

Thyroid Disease: What’s New in Diagnosis and Management?/Combined Modality Approaches to Locally Advanced Non-Small-Cell Lung Cancer (NCME Video 686) pt. 1. Screening — pt. 2. Patient evaluation — pt. 3. Additional tests & management of hypo- and hyperthyroidism — pt. 4. Structural abnormalities and thyroid cancer….

What You Need to Know About Lung Cancer – It’s Your Life, Live It! $84.99 As an Oncology Nurse. I had only one protocol in mind while writing this book. That was to show you the most successful cancer treatments available today for Lung Cancer.To that end, you won’t find a better warrior in the war on cancer than reading this book.We are honored to inform you that many leading hospitals use our books in their medical library to be used by physicians. They are Harvard Un…

Complementary/Holistic Medicine for Non-Small Cell Lung Cancer – It’s Your Life, Live It! $83.72 This book will show you the most successful alternative, natural & complimentary cancer treatments available today for Non-Small Cell Lung cancer.To that end, you won’t find a better warrior in the war on cancer than reading this book.We are honored to inform you that many leading hospitals use our books in their medical library to be used by physicians. They are Harvard University, Columbia, NYU,…

Multimodality Treatment of Lung Cancer (Lung Biology in Health and Disease) $30.55 Edited by the organizer of a pioneering, multidisciplinary clinic for lung cancer patients, now emulated at cancer centers worldwide! This up-to-date reference presents the treatment and management of lung cancer, as well as accurate evaluation and assessment procedures for small-cell and non-small-cell lung cancers, written by experts in various disciplines of the subject, including biology, che…

Lung Cancer Therapy Annual 6 $99.95 Oncology research and practice in lung cancer continues to develop rapidly. This latest edition of Lung Cancer Therapy Annual briefs the oncology community with a review of the recent literature, emphasizing the therapeutic aspects. It offers an update of the impact that this information will have on the day-to-day management of the lung cancer patient. New to the Sixth Edition : new information on approaches to the management of lung cancer the emerging role of “targeted therapy” with small molecules an update on the use of adjuvant therapy in addition to surgery Additional topics include: epidemiology recent advances in the pharmacogenetics of non-small cell lung cancer prevention, early detection, and screening histopathology staging, staging procedures, and prognostic factors treatment of small cell lung cancer treatment of non-small cell lung cancer mesothelioma

Advances in Radiation Oncology in Lung Cancer $329 This volume is devoted to the radiation oncology of lung cancer, considering both non-small cell and small cell lung cancers. State-of-the-art treatment strategies and novel approaches that promise further improvements in outcome are explained and evaluated, with the aid of illustrations. Treatment-related toxicity is discussed and more.

The Official Patient’s Sourcebook on Non-Small Cell Lung Cancer $34.95 This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to non-small cell lung cancer (also nonsmall cell lung cancer), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on non-small cell lung cancer. Given patients’ increasing sophistication in using the Internet, abundant references to reliable Internet-based resources are provided throughout this sourcebook. Where possible, guidance is provided on how to obtain free-of-charge, primary research results as well as more detailed information via the Internet. E-book and electronic versions of this sourcebook are fully interactive with each of the Internet sites mentioned (clicking on a hyperlink automatically opens your browser to the site indicated). Hard-copy users of this sourcebook can type cited Web addresses directly into their browsers to obtain access to the corresponding sites. In addition to extensive references accessible via the Internet, chapters include glossaries of technical or uncommon terms.

Lung Cancer $189.58 Lung cancer remains the leading cause of cancerrelated death in men, and in women, it has surpassed even breast cancer. According to the American Cancer Society, in 2001, there will be about 169,500 new cases of lung cancer in the United States: 90,700 among men and 78,800 among women. Lung Cancer is the second installment in the M. D. Anderson Cancer Care Series, featuring the current standard approach to lung cancer care from the experts at M. D. Anderson Cancer Center. Designed for the practicing oncologist, this clinical guidebook allows for quick, authoritative access to the latest and best multimodality therapies. Topics covered in this volume include the clinical examination of patients with suspected lung cancer, thoracic imaging techniques for nonsmall cell and small cell lung cancer, pathology of lung cancer, treatment and management of nonsmall and smallcell lung cancer, including the role of guidelines and clinical pathways, molecular events in lung cancer and implications for prevention and therapy, palliation, and much more. Each of the 15 chapters ends with an uptodate list of suggested readings, as well as key practice points highlighting the most important principles and practices of each chapter for ataglance reference. Over 50 illustrations and 40 tables round out the text. This thorough, practical volume is the essential clinical guide for oncologists, surgeons, and all physicians involved in the care of patients with lung cancer. Author: Fossella, Frank V./ Komaki, Ritsuko/ Putnam, Joe B. Series Title: M.D. Anderson Cancer Care Series Binding Type: Paperback Number of Pages: 328 Publication Date: 2003/01/01 Language: English Dimensions: 9.28 x 6.20 x 0.56 inches

Advances in Radiation Oncology in Lung Cancer $275.59 New – This is the second, completely updated edition of a comprehensive book in which many of the world’s leading lung cancer specialists discuss the recent advances in the radiation oncology of lung cancer and reflect on the latest research findings. The first three sections cover the basic science of lung cancer, clinical investigations, including histology and staging, and a wide range of fundamental treatment considerations. Current treatment strategies for small cell and non-small cell lung

Advances in Radiation Oncology in Lung Cancer $317.37 New – Although decades of laboratory and clinical research have led to incremental improvement in treatment outcome, lung cancer remains one of the most deadly diseases. This volume is unique in being devoted solely to the radiation oncology of lung cancer, and will be of great value to all who are involved in the diagnosis and treatment of the disease. Both non-small cell and small cell lung cancer are considered in detail. Current state-of-the-art treatment strategies and novel approaches that

Advances in Radiation Oncology in Lung Cancer $260.49 Used – Although decades of laboratory and clinical research have led to incremental improvement in treatment outcome, lung cancer remains one of the most deadly diseases. This volume is unique in being devoted solely to the radiation oncology of lung cancer, and will be of great value to all who are involved in the diagnosis and treatment of the disease. Both non-small cell and small cell lung cancer are considered in detail. Current state-of-the-art treatment strategies and novel approaches tha

Controversies in the Treatment of Lung Cancer: 12th International Symposium on Special Aspects of Radiotherapy, Berlin, October 2008 $99.04 New – Under the auspices of the 12th International Symposium on Special Aspects in Radiotherapy 2008 in Berlin, acknowledged experts presented their perspectives on small and non-small cell lung cancer, reflecting the latest standards and engaging in controversies in the diagnosis and treatment of this disease. In the first part of this volume, aspects of the diagnostic workup are highlighted from the histopathologist’s point of view, followed by presentations concerning the value of PET-CT and